Article Details
Retrieved on: 2024-02-01 16:13:24
Tags for this article:
Click the tags to see associated articles and topics
Summary
GT Biopharma announces a 1-for-30 reverse stock split to comply with Nasdaq's Minimum Bid Price Requirement, a key event in the capital markets concerning corporate finance and equity securities, particularly common stock trading.
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here